Literature DB >> 3950052

Ibuprofen kinetics in plasma and synovial fluid of arthritic patients.

J M Gallo, E P Gall, W R Gillespie, K S Albert, D Perrier.   

Abstract

After administration of a single dose and at steady state, ibuprofen concentrations were measured simultaneously in plasma and synovial fluid obtained from eight patients with rheumatoid arthritis. By seven hours after a dose at steady state, the mean synovial fluid: plasma ibuprofen concentration ratios were constant, and the synovial fluid levels were, on average, greater than those in plasma. The extent to which ibuprofen was bound to protein was somewhat greater in plasma than in synovial fluid. As a result, the mean synovial fluid:plasma free concentration ratio for seven-hour and later specimens was greater than that based on total concentrations. The degree of accumulation of ibuprofen in each fluid was minimal, consistent with its short half-life.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3950052     DOI: 10.1002/j.1552-4604.1986.tb02905.x

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  10 in total

Review 1.  Recent findings on the pharmacokinetics of non-steroidal anti-inflammatory drugs in synovial fluid.

Authors:  P Netter; B Bannwarth; M J Royer-Morrot
Journal:  Clin Pharmacokinet       Date:  1989-09       Impact factor: 6.447

2.  Stereoselective plasma protein binding of ibuprofen enantiomers.

Authors:  A M Evans; R L Nation; L N Sansom; F Bochner; A A Somogyi
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

Review 3.  Development of macromolecular prodrug for rheumatoid arthritis.

Authors:  Fang Yuan; Ling-dong Quan; Liao Cui; Steven R Goldring; Dong Wang
Journal:  Adv Drug Deliv Rev       Date:  2012-03-10       Impact factor: 15.470

4.  Stereoselective drug disposition: potential for misinterpretation of drug disposition data.

Authors:  A M Evans; R L Nation; L N Sansom; F Bochner; A A Somogyi
Journal:  Br J Clin Pharmacol       Date:  1988-12       Impact factor: 4.335

5.  Plasma and synovial fluid meclofenamic acid concentrations in patients with rheumatoid arthritis of the knee.

Authors:  J R Koup; D Thomas; E Tucker; A Black; M Ruderman; J A Dixon; A Kinkel
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

Review 6.  Clinical pharmacokinetics of ibuprofen. The first 30 years.

Authors:  N M Davies
Journal:  Clin Pharmacokinet       Date:  1998-02       Impact factor: 6.447

7.  Comparison of intravenous ibuprofen and tenoxicam efficiency in ankle injury: a randomized, double-blind study.

Authors:  Gonca Koksaldi Sahin; Muge Gulen; Selen Acehan; Deniz Aka Satar; Tahsin Erfen; Salim Satar
Journal:  Ir J Med Sci       Date:  2022-09-13       Impact factor: 2.089

Review 8.  Ibuprofen: pharmacology, efficacy and safety.

Authors:  K D Rainsford
Journal:  Inflammopharmacology       Date:  2009-11-21       Impact factor: 4.473

9.  Bioequivalence assessment of two formulations of ibuprofen.

Authors:  Zeyad A Al-Talla; Sabah H Akrawi; Luke T Tolley; Salim H Sioud; Mohammed F Zaater; Abdul-Hamid M Emwas
Journal:  Drug Des Devel Ther       Date:  2011-10-19       Impact factor: 4.162

10.  Penetration and efficacy of transdermal NSAIDs in a model of acute joint inflammation.

Authors:  David Charles Baranowski; Beth Buchanan; Heather C Dwyer; Joseph P Gabriele; Stephanie Kelly; Joseph A Araujo
Journal:  J Pain Res       Date:  2018-11-13       Impact factor: 3.133

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.